Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|April 15, 2010
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinomaFumihiko Kanai, Haruhiko Yoshida, Ryosuke Tateishi, et al.Hepato-Gastroenterology|December 13, 2006
Age-related comparison of the profiles of patients with hepatocellular carcinomaTomonori Fujishima, Takashi Ishikawa, Yasushi Shiratori, et al.Liver Cancer|September 26, 2022
Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted TreatmentKazuomi Ueshima, Atsushi Komemushi, Takeshi Aramaki, et al.Proteomics|October 29, 2005
Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatmentTakayuki Kawakami, Yujin Hoshida, Fumihiko Kanai, et al.Viruses|November 27, 2021
The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus InfectionHiroyuki Amano, Tatsuo Kanda, Hitoshi Mochizuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[A Resected Case of Synchronous Double Cancer of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma]Hiroyuki Nojima, Hiroaki Shimizu, Takashi Fujino, et al.Liver Cancer|June 12, 2018
Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II StudyMasatoshi Kudo, Yoon-Koo Kang, Joong-Won Park, et al.Journal of Gastroenterology|April 4, 2003
Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liverYasuo Tanaka, Masaki Takayanagi, Yasushi Shiratori, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 30, 2018
Multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon-α combination therapy for hepatocellular carcinoma with extrahepatic metastasesHiroaki Nagano, Shuntaro Obi, Etsuro Hatano, et al.Hepatology International|January 24, 2019
The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world settingShuntaro Obi, Takahisa Sato, Shinpei Sato, et al.Pageof 7